Cargando…
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial
Ibudilast, a neuroimmune modulator which selectively inhibits phosphodiesterases (PDE)-3, -4, -10, and -11, and macrophage migration inhibitory factor (MIF), shows promise as a novel pharmacotherapy for alcohol use disorder (AUD). However, the mechanisms of action underlying ibudilast’s effects on t...
Autores principales: | Grodin, Erica N., Bujarski, Spencer, Towns, Brandon, Burnette, Elizabeth, Nieto, Steven, Lim, Aaron, Lin, Johnny, Miotto, Karen, Gillis, Artha, Irwin, Michael R., Evans, Christopher, Ray, Lara A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197758/ https://www.ncbi.nlm.nih.gov/pubmed/34120149 http://dx.doi.org/10.1038/s41398-021-01478-5 |
Ejemplares similares
-
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
por: Burnette, Elizabeth M., et al.
Publicado: (2020) -
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
por: Burnette, Elizabeth M., et al.
Publicado: (2022) -
Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers
por: Grodin, Erica N., et al.
Publicado: (2020) -
A novel human laboratory model for screening medications for alcohol use disorder
por: Ho, Diana, et al.
Publicado: (2020) -
Role of phosphodiesterase inhibitor Ibudilast in morphine-induced hippocampal injury
por: Zhaleh, Mohsen, et al.
Publicado: (2014)